layout.fixed.naaccr.doc.naaccr18.ajccTnmPostTherapyTSuffix.html Maven / Gradle / Ivy


    
        Item #
        Length
        Source of Standard
        Year Implemented
        Version Implemented
        Year Retired
        Version Retired
        Column #
    
    
        1033
        4
        AJCC
        2018
        18
        
        
        1233 - 1236
    



NAACCR XML: Tumor.ajccTnmPostTherapyTSuffix




Description
Detailed site-specific codes for the postneoadjuvant therapy T category suffix as defined by AJCC.

Clinical, pathological, and postneoadjuvant therapy stage data are given three separate areas in the NAACCR Data Exchange Record Layout.

Rationale
CoC requires that AJCC TNM staging be used in its approved cancer programs. AJCC developed its staging system for evaluating trends in the treatment and control of cancer. This staging is used by physicians to estimate prognosis, to plan treatment, to evaluate new types of therapy, to analyze outcome, to design follow-up strategies, and to assess early detection results.
Codes (as published in the AJCC Cancer Staging Manual)

    
        
            (m)
            Multiple synchronous tumors
                OR
                For thyroid differentiated and anaplastic only, Multifocal tumor
            
        
        
            (s)
            For thyroid differentiated and anaplastic only, Solitary tumor
        
        
            Blank
            No information available; not recorded
        
        
            
        
    

Note: Refer to the current AJCC Cancer Staging Manual for staging rules.

(m)	Multiple synchronous tumors OR For thyroid differentiated and anaplastic only, Multifocal tumor
(s)	For thyroid differentiated and anaplastic only, Solitary tumor
Blank	No information available; not recorded